INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,216 | -26.0% | 3,201 | -12.7% | 0.00% | 0.0% |
| Q1 2023 | $136,706 | +2.7% | 3,668 | -3.8% | 0.00% | 0.0% |
| Q4 2022 | $133,070 | -44.1% | 3,814 | -8.4% | 0.00% | 0.0% |
| Q3 2022 | $238,000 | +7.2% | 4,163 | -4.5% | 0.00% | 0.0% |
| Q2 2022 | $222,000 | -39.7% | 4,361 | -13.8% | 0.00% | 0.0% |
| Q1 2022 | $368,000 | -43.8% | 5,061 | -8.6% | 0.00% | -50.0% |
| Q4 2021 | $655,000 | -20.2% | 5,539 | -9.5% | 0.00% | -33.3% |
| Q3 2021 | $821,000 | -89.9% | 6,123 | -87.8% | 0.00% | -91.4% |
| Q2 2021 | $8,097,000 | +100.9% | 50,008 | -0.4% | 0.04% | +169.2% |
| Q1 2021 | $4,030,000 | +599.7% | 50,219 | +373.9% | 0.01% | +550.0% |
| Q4 2020 | $576,000 | – | 10,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |